Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56676 - 56700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	SIX6	4990	downregulated	panobinostat results in decreased expression of SIX6 mRNA	14q23.1	A21037
Panobinostat	Approved Investigational	SKAP2	8935	upregulated	panobinostat results in increased expression of SKAP2 mRNA	7p15.2	A21037
Panobinostat	Approved Investigational	SLC16A1	6566	upregulated	panobinostat results in increased expression of SLC16A1 mRNA	1p13.2	A21037
Panobinostat	Approved Investigational	SLC16A14	151473	downregulated	panobinostat results in decreased expression of SLC16A14 mRNA	2q36.3	A21037
Panobinostat	Approved Investigational	SLC16A4	9122	upregulated	panobinostat results in increased expression of SLC16A4 mRNA	1p13.3	A21037
Panobinostat	Approved Investigational	SLC18B1	116843	upregulated	panobinostat results in increased expression of SLC18B1 mRNA	6q23.2	A21037
Panobinostat	Approved Investigational	SLC19A3	80704	upregulated	panobinostat results in increased expression of SLC19A3 mRNA	2q36.3	A21037
Panobinostat	Approved Investigational	SLC1A3	6507	upregulated	panobinostat results in increased expression of SLC1A3 mRNA	5p13.2	A21037
Panobinostat	Approved Investigational	SLC24A3	57419	upregulated	panobinostat results in increased expression of SLC24A3 mRNA	20p11.23	A21037
Panobinostat	Approved Investigational	SLC25A12	8604	upregulated	panobinostat results in increased expression of SLC25A12 mRNA	2q31.1	A21037
Panobinostat	Approved Investigational	SLC25A16	8034	upregulated	panobinostat results in increased expression of SLC25A16 mRNA	10q21.3	A21037
Panobinostat	Approved Investigational	SLC25A53	401612	downregulated	panobinostat results in decreased expression of SLC25A53 mRNA	Xq22.2	A21037
Panobinostat	Approved Investigational	SLC2A3	6515	upregulated	panobinostat results in increased expression of SLC2A3 mRNA	12p13.31	A21037
Panobinostat	Approved Investigational	SLC30A4	7782	upregulated	panobinostat results in increased expression of SLC30A4 mRNA	15q21.1	A21037
Panobinostat	Approved Investigational	SLC35F2	54733	upregulated	panobinostat results in increased expression of SLC35F2 mRNA	11q22.3	A21037
Panobinostat	Approved Investigational	SLC39A6	25800	downregulated	panobinostat results in decreased expression of SLC39A6 mRNA	18q12.2	A21037
Panobinostat	Approved Investigational	SLC39A8	64116	upregulated	panobinostat results in increased expression of SLC39A8 mRNA	4q24	A21037
Panobinostat	Approved Investigational	SLC40A1	30061	upregulated	panobinostat results in increased expression of SLC40A1 mRNA	2q32.2	A21037
Panobinostat	Approved Investigational	SLC43A1	8501	upregulated	panobinostat results in increased expression of SLC43A1 mRNA	11q12.1	A21037
Panobinostat	Approved Investigational	SLC52A3	113278	upregulated	panobinostat results in increased expression of SLC52A3 mRNA	20p13	A21037
Panobinostat	Approved Investigational	SLC6A8	6535	downregulated	panobinostat results in decreased expression of SLC6A8 mRNA	Xq28	A21037
Panobinostat	Approved Investigational	SLC7A10	56301	upregulated	panobinostat results in increased expression of SLC7A10 mRNA	19q13.11	A21037
Panobinostat	Approved Investigational	SLC7A11	23657	upregulated	panobinostat results in increased expression of SLC7A11 mRNA	4q28.3	A21037
Panobinostat	Approved Investigational	SLC7A5	8140	upregulated	panobinostat results in increased expression of SLC7A5 mRNA	16q24.2	A21037
Panobinostat	Approved Investigational	SLC9B2	133308	downregulated	panobinostat results in decreased expression of SLC9B2 mRNA	4q24	A21037

Displaying entries 56676 - 56700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability